(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PTPRD mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:1558606 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PTPRD mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression ISO RGD:1558606 6480464 ethylene dichloride results in decreased expression of PTPRD mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1558606 6480464 1, 2-Dimethylhydrazine results in decreased expression of PTPRD mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of PTPRD mRNA CTD PMID:25380136 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of PTPRD mRNA CTD PMID:12655037 , PMID:15576828 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:20959002 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1348083 6480464 Tetrachlorodibenzodioxin affects the expression of PTPRD mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1558606 6480464 Tetrachlorodibenzodioxin results in decreased expression of PTPRD mRNA CTD PMID:15034205 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PTPRD mRNA CTD PMID:16054898 more ... 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of PTPRD mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of PTPRD mRNA CTD PMID:21346803 2-butoxyethanol decreases expression ISO RGD:1558606 6480464 n-butoxyethanol results in decreased expression of PTPRD mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1558606 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of PTPRD mRNA CTD PMID:26251327 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of PTPRD mRNA CTD PMID:28522335 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of PTPRD mRNA CTD PMID:25380136 4-hydroxyphenyl retinamide decreases expression ISO RGD:1558606 6480464 Fenretinide results in decreased expression of PTPRD mRNA CTD PMID:28973697 aflatoxin B1 affects expression ISO RGD:1348083 6480464 Aflatoxin B1 affects the expression of PTPRD protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:1348083 6480464 Aflatoxin B1 results in decreased methylation of PTPRD gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1558606 6480464 Aflatoxin B1 results in decreased expression of PTPRD mRNA CTD PMID:19770486 Aflatoxin B2 alpha increases methylation ISO RGD:1348083 6480464 aflatoxin B2 results in increased methylation of PTPRD intron CTD PMID:30157460 all-trans-retinoic acid decreases expression ISO RGD:1348083 6480464 Tretinoin results in decreased expression of PTPRD mRNA CTD PMID:23724009 aristolochic acid A decreases expression ISO RGD:1348083 6480464 aristolochic acid I results in decreased expression of PTPRD mRNA CTD PMID:33212167 benzo[a]pyrene multiple interactions ISO RGD:1558606 6480464 AHR protein promotes the reaction [Benzo(a)pyrene results in decreased expression of PTPRD mRNA] CTD PMID:15034205 benzo[a]pyrene decreases expression ISO RGD:1348083 6480464 Benzo(a)pyrene results in decreased expression of PTPRD mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:1348083 6480464 Benzo(a)pyrene results in increased methylation of PTPRD promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1348083 6480464 Benzo(a)pyrene affects the methylation of PTPRD 5' UTR, Benzo(a)pyrene affects the methylation of PTPRD intron CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene decreases expression ISO RGD:1558606 6480464 Benzo(a)pyrene results in decreased expression of PTPRD mRNA CTD PMID:15034205 , PMID:19770486 benzo[e]pyrene increases methylation ISO RGD:1348083 6480464 benzo(e)pyrene results in increased methylation of PTPRD intron CTD PMID:30157460 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of PTPRD mRNA CTD PMID:15651846 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PTPRD mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:1348083 6480464 bisphenol A results in increased methylation of PTPRD gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:1558606 6480464 bisphenol A results in decreased expression of PTPRD mRNA CTD PMID:33221593 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PTPRD mRNA CTD PMID:30816183 butanal decreases expression ISO RGD:1348083 6480464 butyraldehyde results in decreased expression of PTPRD mRNA CTD PMID:26079696 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PTPRD mRNA CTD PMID:25993096 calcitriol decreases expression ISO RGD:1348083 6480464 Calcitriol results in decreased expression of PTPRD mRNA CTD PMID:26485663 casticin decreases expression ISO RGD:1558606 6480464 casticin results in decreased expression of PTPRD mRNA CTD PMID:28444820 CGP 52608 multiple interactions ISO RGD:1348083 6480464 CGP 52608 promotes the reaction [RORA protein binds to PTPRD gene] CTD PMID:28238834 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of PTPRD mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1558606 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PTPRD mRNA CTD PMID:20938992 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of PTPRD mRNA CTD PMID:22023808 clofibrate multiple interactions ISO RGD:1558606 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PTPRD mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PTPRD mRNA] CTD PMID:17585979 clofibrate increases expression ISO RGD:1558606 6480464 Clofibrate results in increased expression of PTPRD mRNA CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PTPRD mRNA CTD PMID:17602206 cumene decreases expression ISO RGD:1558606 6480464 cumene results in decreased expression of PTPRD mRNA CTD PMID:18648096 cyclosporin A decreases expression ISO RGD:1558606 6480464 Cyclosporine results in decreased expression of PTPRD mRNA CTD PMID:19770486 dexamethasone increases expression ISO RGD:1558606 6480464 Dexamethasone results in increased expression of PTPRD mRNA CTD PMID:22733784 diazinon increases expression EXP 6480464 Diazinon results in increased expression of PTPRD mRNA CTD PMID:29108742 dibutyl phthalate increases expression ISO RGD:1558606 6480464 Dibutyl Phthalate results in increased expression of PTPRD mRNA CTD PMID:21266533 dioxygen multiple interactions ISO RGD:1558606 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PTPRD mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PTPRD mRNA CTD PMID:33729688 dorsomorphin multiple interactions ISO RGD:1348083 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1558606 6480464 Doxorubicin results in decreased expression of PTPRD mRNA CTD PMID:19277126 doxorubicin decreases expression ISO RGD:1348083 6480464 Doxorubicin results in decreased expression of PTPRD mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PTPRD mRNA CTD PMID:29391264 ethanol decreases expression ISO RGD:1558606 6480464 Ethanol results in decreased expression of PTPRD mRNA CTD PMID:29018328 ethanol affects expression ISO RGD:1558606 6480464 Ethanol affects the expression of PTPRD mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1558606 6480464 Ethanol affects the expression of and affects the splicing of PTPRD mRNA CTD PMID:30319688 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of PTPRD mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1558606 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PTPRD mRNA CTD PMID:20938992 furan decreases expression EXP 6480464 furan results in decreased expression of PTPRD mRNA CTD PMID:26194646 geldanamycin increases expression ISO RGD:1348083 6480464 geldanamycin results in increased expression of PTPRD mRNA CTD PMID:26705709 Heliotrine decreases expression ISO RGD:1348083 6480464 heliotrine results in decreased expression of PTPRD mRNA CTD PMID:26100227 irinotecan increases expression ISO RGD:1348083 6480464 Irinotecan metabolite results in increased expression of PTPRD mRNA, Irinotecan results in increased expression of PTPRD mRNA CTD PMID:15956246 isoprenaline decreases expression ISO RGD:1558606 6480464 Isoproterenol results in decreased expression of PTPRD mRNA CTD PMID:21335049 ivermectin decreases expression ISO RGD:1348083 6480464 Ivermectin results in decreased expression of PTPRD protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1558606 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PTPRD mRNA CTD PMID:20938992 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of PTPRD mRNA CTD PMID:28801915 methapyrilene increases methylation ISO RGD:1348083 6480464 Methapyrilene results in increased methylation of PTPRD intron CTD PMID:30157460 mono(2-ethylhexyl) phthalate increases expression ISO RGD:1558606 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of PTPRD mRNA CTD PMID:22401849 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of PTPRD mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PTPRD mRNA, [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of PTPRD mRNA CTD PMID:17602206 , PMID:28943392 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of PTPRD mRNA CTD PMID:25380136 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of PTPRD mRNA CTD PMID:24136188 nickel atom decreases expression ISO RGD:1348083 6480464 Nickel results in decreased expression of PTPRD mRNA CTD PMID:24768652 , PMID:25583101 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of PTPRD mRNA CTD PMID:24136188 O-methyleugenol decreases expression ISO RGD:1348083 6480464 methyleugenol results in decreased expression of PTPRD mRNA CTD PMID:32234424 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of PTPRD mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] affects the expression of PTPRD mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1558606 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of PTPRD mRNA CTD PMID:34911549 paracetamol multiple interactions ISO RGD:1558606 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of PTPRD mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of PTPRD mRNA] CTD PMID:17585979 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PTPRD mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:1558606 6480464 Acetaminophen affects the expression of PTPRD mRNA CTD PMID:17562736 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of PTPRD mRNA CTD PMID:32680482 pentachlorophenol decreases expression ISO RGD:1558606 6480464 Pentachlorophenol results in decreased expression of PTPRD mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid affects expression ISO RGD:1558606 6480464 perfluorooctane sulfonic acid affects the expression of PTPRD mRNA CTD PMID:19429403 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1558606 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PTPRD mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of PTPRD mRNA CTD PMID:19162173 perfluorooctanoic acid affects expression ISO RGD:1558606 6480464 perfluorooctanoic acid affects the expression of PTPRD mRNA CTD PMID:19429403 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of PTPRD mRNA CTD PMID:16940010 phenobarbital affects expression ISO RGD:1558606 6480464 Phenobarbital affects the expression of PTPRD mRNA CTD PMID:23091169 pirinixic acid decreases expression ISO RGD:1558606 6480464 pirinixic acid results in decreased expression of PTPRD mRNA CTD PMID:18445702 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of PTPRD mRNA CTD PMID:19162173 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1558606 6480464 Pregnenolone Carbonitrile results in decreased expression of PTPRD mRNA CTD PMID:28903501 propiconazole decreases expression ISO RGD:1558606 6480464 propiconazole results in decreased expression of PTPRD mRNA CTD PMID:21278054 rotenone increases expression EXP 6480464 Rotenone results in increased expression of PTPRD mRNA CTD PMID:19013527 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PTPRD mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1348083 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 senecionine decreases expression ISO RGD:1348083 6480464 senecionine results in decreased expression of PTPRD mRNA CTD PMID:26100227 senecionine decreases expression ISO RGD:1558606 6480464 senecionine results in decreased expression of PTPRD protein CTD PMID:35357534 Senkirkine decreases expression ISO RGD:1348083 6480464 senkirkine results in decreased expression of PTPRD mRNA CTD PMID:26100227 silicon dioxide increases expression ISO RGD:1348083 6480464 Silicon Dioxide analog results in increased expression of PTPRD mRNA CTD PMID:23806026 sodium arsenite affects methylation ISO RGD:1348083 6480464 sodium arsenite affects the methylation of PTPRD gene CTD PMID:28589171 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of PTPRD mRNA CTD PMID:25993096 streptozocin multiple interactions EXP 6480464 [Streptozocin co-treated with Dietary Fats] results in decreased expression of PTPRD mRNA CTD PMID:20665664 temozolomide decreases expression ISO RGD:1348083 6480464 Temozolomide results in decreased expression of PTPRD mRNA CTD PMID:31758290 testosterone enanthate affects expression ISO RGD:1348083 6480464 testosterone enanthate affects the expression of PTPRD mRNA CTD PMID:17440010 tetrachloromethane decreases expression ISO RGD:1558606 6480464 Carbon Tetrachloride results in decreased expression of PTPRD mRNA CTD PMID:27339419 , PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PTPRD mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PTPRD mRNA] CTD PMID:31150632 thapsigargin increases expression ISO RGD:1558606 6480464 Thapsigargin results in increased expression of PTPRD protein CTD PMID:24648495 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PTPRD mRNA CTD PMID:23411599 , PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in decreased expression of PTPRD mRNA CTD PMID:28943392 titanium dioxide decreases expression ISO RGD:1558606 6480464 titanium dioxide results in decreased expression of PTPRD mRNA CTD PMID:27760801 toluene increases expression EXP 6480464 Toluene results in increased expression of PTPRD mRNA CTD PMID:22967744 topotecan increases expression EXP 6480464 Topotecan results in increased expression of PTPRD mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] affects the expression of PTPRD mRNA CTD PMID:25729387 trichostatin A decreases expression ISO RGD:1348083 6480464 trichostatin A results in decreased expression of PTPRD mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1348083 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTPRD mRNA CTD PMID:27188386 trimellitic anhydride decreases expression ISO RGD:1558606 6480464 trimellitic anhydride results in decreased expression of PTPRD mRNA CTD PMID:19042947 triptonide decreases expression ISO RGD:1558606 6480464 triptonide results in decreased expression of PTPRD mRNA CTD PMID:33045310 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of PTPRD mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:1348083 6480464 Valproic Acid results in decreased methylation of PTPRD gene CTD PMID:29154799 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of PTPRD mRNA CTD PMID:29427782 valproic acid multiple interactions ISO RGD:1348083 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PTPRD mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1348083 6480464 Valproic Acid results in decreased expression of PTPRD mRNA CTD PMID:23527032 more ... valproic acid affects expression ISO RGD:1558606 6480464 Valproic Acid affects the expression of PTPRD mRNA CTD PMID:17963808 vancomycin increases expression ISO RGD:1558606 6480464 Vancomycin results in increased expression of PTPRD mRNA CTD PMID:18930951 vinclozolin increases methylation EXP 6480464 vinclozolin results in increased methylation of PTPRD gene CTD PMID:31079544 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of PTPRD mRNA CTD PMID:20566332 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PTPRD mRNA CTD PMID:19015723 vitamin E decreases expression ISO RGD:1348083 6480464 Vitamin E results in decreased expression of PTPRD mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:1348083 6480464 vorinostat results in decreased expression of PTPRD mRNA CTD PMID:27188386 zinc atom increases expression EXP 6480464 Zinc results in increased expression of PTPRD mRNA CTD PMID:17074742 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of PTPRD mRNA CTD PMID:17074742 zinc(0) increases expression EXP 6480464 Zinc results in increased expression of PTPRD mRNA CTD PMID:17074742